The following represents disclosure information provided by authors of this abstract. The Breast Cancer Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Evaluation of ER/PR and HER2 status by RNA sequencing in tissue core biopsies from preoperative clinical trial specimens.
S. Kamalakaran
Employment or Leadership Position - Philips Research
K. Lezon-Geyda
No relevant relationships to disclose
V. Varadan
Employment or Leadership Position - Philips Research
N. Banerjee
Employment or Leadership Position - Philips Research
D. R. Lannin
No relevant relationships to disclose
T. Rizack
No relevant relationships to disclose
W. M. Sikov
No relevant relationships to disclose
M. M. Abu-Khalaf
Consultant or Advisory Role - Abraxis BioScience
Research Funding - Abraxis BioScience; Genentech
A. Janevski
Employment or Leadership Position - Philips Research
L. Harris
Research Funding - Abraxis BioScience; Genentech